Gene · 25942
Papers3,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration. | Pathophysiology | 2023 | 37606389 | PubTator, text mining | PubMed |
| Wnt3a signaling with serum supply induces replication stress in cultured cells. | Biochem Biophys Rep | 2023 | 37601449 | PubTator, text mining | PubMed |
| Early diagnostic and prognostic biomarkers for gastric cancer: systems-level molecular basis of subsequent alterations in gastric mucosa from chronic atrophic gastritis to gastric cancer. | J Genet Eng Biotechnol | 2023 | 37594635 | PubTator, text mining | PubMed |
| SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. | JCI Insight | 2023 | 37581938 | PubTator, text mining | PubMed |
| HDAC1/2/3 are major histone desuccinylases critical for promoter desuccinylation. | Cell Discov | 2023 | 37580347 | PubTator, text mining | PubMed |
Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma. | Front Immunol | 2023 | 37575252 | PubTator, text mining | PubMed |
| HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation. | Cell Chem Biol | 2023 | 37572669 | PubTator, text mining | PubMed |
| Pictilisib-Induced Resistance Is Mediated through FOXO1-Dependent Activation of Receptor Tyrosine Kinases in Mucinous Colorectal Adenocarcinoma Cells. | Int J Mol Sci | 2023 | 37569713 | PubTator, text mining | PubMed |
| TET (Ten-eleven translocation) family proteins: structure, biological functions and applications. | Signal Transduct Target Ther | 2023 | 37563110 | PubTator, text mining | PubMed |
| Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds. | Pharmaceuticals (Basel) | 2023 | 37513880 | PubTator, text mining | PubMed |
| Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects. | Pharmaceuticals (Basel) | 2023 | 37513835 | PubTator, text mining | PubMed |
| Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings. | Cancers (Basel) | 2023 | 37509385 | PubTator, text mining | PubMed |
| NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor. | Cancers (Basel) | 2023 | 37509312 | PubTator, text mining | PubMed |
| CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2023 | 37509260 | PubTator, text mining | PubMed |
| Super-enhancers complexes zoom in transcription in cancer. | J Exp Clin Cancer Res | 2023 | 37501079 | PubTator, text mining | PubMed |
| Deep immunophenotyping reveals clinically distinct cellular states and ecosystems in large-scale colorectal cancer. | Commun Biol | 2023 | 37500893 | PubTator, text mining | PubMed |
| VBASS enables integration of single cell gene expression data in Bayesian association analysis of rare variants. | Commun Biol | 2023 | 37491581 | PubTator, text mining | PubMed |
| Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities. | Nat Struct Mol Biol | 2023 | 37488358 | PubTator, text mining | PubMed |
| Proliferating cell nuclear antigen inhibitors block distinct stages of herpes simplex virus infection. | PLoS Pathog | 2023 | 37486931 | PubTator, text mining | PubMed |
| Functional role of SAP18 protein: From transcriptional repression to splicing regulation. | Cell Biochem Funct | 2023 | 37486712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25942/papers?page=12